Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Eliminating paper drug labeling such as package inserts in favor of e-labels could compromise the availability of information for some patients, physicians and pharmacists, a government study found.
The Government Accountability Office (GAO) sought input on the partial or complete substitution of e-labels from the FDA, patient advocates, pharmacy groups, manufacturers, and medical societies including the American Medical Association, American Congress of Obstetricians and Gynecologists, and American Academy of Physician Assistants.
0 Comments
View Comments
Related Content
Comments